Lactose (India) Limited (BOM:524202)
115.60
-5.55 (-4.58%)
At close: May 26, 2026
Lactose (India) Revenue
In the fiscal year ending March 31, 2026, Lactose (India) had annual revenue of 1.63B INR with 40.28% growth. Lactose (India) had revenue of 457.66M in the quarter ending March 31, 2026, with 64.80% growth.
Revenue
1.63B
Revenue Growth
+40.28%
P/S Ratio
0.89
Revenue / Employee
11.66M
Employees
140
Market Cap
1.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.63B | 468.91M | 40.28% |
| Mar 31, 2025 | 1.16B | 25.10M | 2.20% |
| Mar 31, 2024 | 1.14B | 480.94M | 73.09% |
| Mar 31, 2023 | 657.96M | 198.57M | 43.23% |
| Mar 31, 2022 | 459.39M | 109.76M | 31.39% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bilcare | 7.40B |
| Bal Pharma | 3.09B |
| Parnax Lab | 2.28B |
| Aayush Wellness | 1.29B |
| Oxygenta Pharmaceutical | 1.13B |
| Accretion Pharmaceuticals | 898.18M |
| Coral Laboratories | 875.55M |
| Sanjivani Paranteral | 686.66M |